Ajanta Pharma gets US FDA nod for migraine pain relief drug
Ajanta Pharma USA is scheduled to launch the almotriptan malate tablets in the US shortly
Ajanta Pharma has received final…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Ajanta Pharma
Ajanta Pharma Q3 net up 20 per cent at Rs 111.3 crore
Net sales of the company rose to Rs 465.71 crore for the December quarter
Ajanta Pharma has reported a 19.60 per cent increase in…
Ajanta Pharma launches montelukast IR and montelukast chewable tablets
US FDA has approved montelukast offerings in three dosage forms viz immediate-release tablets, chewable tablets, and oral granules…
Ajanta Pharma posts Rs 438 crore consolidated revenue in Q2 of FY 2015-16
EBITDA growth was at Rs 154 crore
Ajanta Pharma has reported its performance for the second quarter and half year ended September…
Ajanta Pharma bags recognition from Fortune India
The company has been ranked as the third largest wealth creator
Ajanta Pharma has been ranked as the third largest wealth creator…
Ajanta Pharma posts Rs 84-crore consolidated profit in Q1FY 2015-16
EBITDA grew 26 per cent at Rs 123 crore
Ajanta Pharma has reported today its performance for the first quarter ended June 30,…
Ajanta Pharma gets approvals for three ANDAs
Montelukast tablets are indicated for the treatment of prophylaxis and chronic treatment of asthma and to relieve symptoms of…
Ajanta Pharma posts Q4 FY ’15 results
Standalone Q4 revenue has shown a growth of 19 per cent and PAT growth of 20 per cent
Ajanta Pharma has posted its performance…
Ajanta Pharma posts standalone and third quarter results
Board of Directors has approved sub-division of nominal value of equity shares of the company from Rs 5 each to nominal value of…